课题基金 / 基金详情

Molecular basis of cancer diathesis

Molecular basis of cancer diathesis
癌症素质的分子基础
批准号:
14032201
负责人:
OKADA Masato
金额:
$60.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

OKADA Masato的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To develop new strategies to suppress carcinogenesis and to control cancer progression, it is critical to understand the fundamental roles and regulatory features of proto-oncogene and anti-oncogene products at the molecular level. In this study, we extensively analyzed the normal functions and regulation of the src family of proto-oncogene products (SFK) in order to understand the role played by SFK in cancer progression, and particularly in the acquisition of metastatic activity.1. Studies of epithelial cancer cells and mutant mice that lack Csk, a negative regulator of SFK, revealed that SFK plays critical roles in cell migration and in the regulation of the epithelial-like cell to mesencymal-like cell transition (EMT). It was also found that SFK is involved in the cell-cell adhesion required for the maintenance of cell polarity and for the regulation of cell proliferation through the control of cytoskeletal organization. Cortactin, an actin binding protein, and its associated molec … More ules were identified as potential targets of SFK in the epithelial-like cell to mesencymal-like cell transition. Furthermore, Csk acted as the critical regulator of these phenomena, suggesting that Csk could be used as a potential therapeutic target to control cancer progression and/or metastasis. 2. In the lipid raft fraction that provides a platform for SFK signaling, we identified a novel membrane phosphoprotein Cbp (Csk binding protein) as an initial target of SFK, and showed that it serves as a membrane scaffold protein for Csk. 3. To analyze the fundamental roles of SFK in animals, we identified SFK and Csk orthologues in C. elegans. Analysis of mutant worms revealed that SRC-1, an orthologue of Src, plays an essential role in controlling the migration of specific cell types during organogenesis. The Rac signaling pathway was identified as a downstream target of SRC-1. 4. Based on the structural information provided by the crystal structure of Csk, we proposed a molecular basis for SFK regulation by Csk. Less
期刊论文(67)
专著(0)
科研奖励(0)
会议论文
Shimizu, K.: "SCOP, a novel binding partner of K-Ras in the membrane rafts, negatively regulates MAPK pathway"J. Biol. Chem.. (in press). (2003)
Shimizu, K.:“SCOP 是膜筏中 K-Ras 的一种新型结合伴侣,对 MAPK 通路具有负调节作用”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Rengifo-Cam W.: "Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells-implication for a potential role in cancer metastasis"Oncogene. 23. 289-297 (2004)
Rengifo-Cam W.:“Csk 定义了人类结肠癌细胞中整合素介导的细胞粘附和迁移的能力 - 暗示在癌症转移中的潜在作用”Oncogene。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1083/jcb.200401093
发表时间: 2004-08-02
期刊: The Journal of cell biology
影响因子: --
作者: [Fukuhara T, Shimizu K, Kawakatsu T, Fukuyama T, Minami Y, Honda T, Hoshino T, Yamada T, Ogita H, Okada M, Takai Y]
通讯作者: Takai Y
Gu J.: "Csk regulates integrin-mediated signals : involvement of differential activation of ERK and Akt"Biochem Biophys Res Commun.. 303. 973-977 (2003)
Gu J.:“Csk 调节整合素介导的信号:参与 ERK 和 Akt 的差异激活”Biochem Biophys Res Commun.. 303. 973-977 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Bayesian theory for spectral deconvolution and its expansion
    • 批准号:
      24654118
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2012
    • 负责人:
      OKADA Masato
    • 依托单位:
    Probabilistic model for non-photorealistic image based on view point and its application to computer graphics
    • 批准号:
      22650041
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.05万
    • 财政年份:
      2010
    • 负责人:
      OKADA Masato
    • 依托单位:
    Regulation of tumor growth via intracellular membrane compartments
    • 批准号:
      22240088
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.12万
    • 财政年份:
      2010
    • 负责人:
      OKADA Masato
    • 依托单位:
    Visualization of a picture for information science and computer science
    • 批准号:
      20240020
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.28万
    • 财政年份:
      2008
    • 负责人:
      OKADA Masato
    • 依托单位:
    国内基金
    海外基金
    5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
    • 批准号:
      82372743
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陈卓佳
    • 依托单位:
    脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
    • 批准号:
      82371223
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      闻大翔
    • 依托单位:
    丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
    • 批准号:
      82373139
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      李孟鸿
    • 依托单位:
    均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
    • 批准号:
      82372089
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      李万万
    • 依托单位: